News

Merck's $3.9B SpringWorks deal, Hims & Hers' Wegovy partnership, CVS exiting Obamacare, and FDA updates on key drugs.
CVS's decision to withdraw from the Affordable Care Act's individual markets could leave nearly a million Americans without ...